CAS: 1647-26-3; 1-Bromo-2-Cyclohexylethane

该化合物是一种溴化烷衍生物,含有环己基替代成分,通常用作有机合成的中间体,其结构由环己环的溴乙基组组成,它对于对烷基反应和更为复杂的环己烷化合物的准备具有价值,由于溴原子的存在,该产品具有高度的回活动性,从而能够高效地进行核循环替代过程.在标准条件下,该化合物的稳定性确保了处理和储存的便利性.该化合物在制药和农用化学研究中特别有用,因为通常需要环己环环环框架.其一贯的纯度和定义明确的再活动特征使得它成为合成应用的可靠选择.

结构式图片

相似化合物

2550-36-9 35541-75-4 57702-84-8

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

cyclohexylethan-1-ol bis-(2-cyclohexyl-ethyl)-ether Vinyl bromide cyclohexylmercury chloride 1-(2-cyclohexyl-ethyl)-piperidine 4-(2-cyclohexyl-ethyl)-morpholine 4-(2-cyclohexyl-ethyl)-4-methyl-morpholinium; bromide 3-(2-cyclohexyl-ethyl)-4-methyl-thiazolium; bromide

合成工艺路线路线简述

    环己基乙酸置于吡啶,六甲基磷酰三胺,Lithium Aluminium Tetrahydride,Sodium Bromide体系中,用 四氢呋喃,丙酮 用作溶剂,化学反应 28.0H,反应生成2-环己基溴乙烷
    参考文献:4-氨基-4-芳基环己酮及其衍生物:一类新型的止痛药.2.羰基官能团的修饰.
    标题:4-氨基-4-芳基环己酮及其衍生物:一类新型的止痛药.2.羰基官能团的修饰.
    摘要:通过还原和添加亲核试剂,研究了对衍生自4-(二甲氨基)-4-芳基环己-1-酮的镇痛药的羰基官能团修饰的影响.分离得到的氨基醇,并基于x射线晶体学,NMR和tlc迁移率确定结构.反式(oh和n)异构体总是比顺式更有效.在距含碳羟基至少两个碳原子的距离处包含平坦的亲脂性部分(苯基,环己烯基)导致效力增加了几个数量级.讨论了其对受体相互作用的可能意义.
    Doi:10.1021/jm00136A010

    海关参考信息

    专利信息


    专利号:US-2005192265-A1
    优先权日:2003-03-20
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:THOMPSON RICHARD C; WILKIE STEPHEN; STACK DOUGLAS R; VANMETER ELDON E; SHI QING; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; HENRY STEVEN S; MCDANIEL STACEY L; STUCKY RUSSELL D; PORTER WARREN J
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:WO-9967219-A1
    优先权日:1998-06-22
    标 题:Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
    发明人:AUDIA JAMES E; PORTER WARREN J; THOMPSON RICHARD C; WILKIE STEPHEN C; STACK DOUGLAS R; SHI QING
    权利人:ELAN PHARM INC; LILLY CO ELI; AUDIA JAMES E; PORTER WARREN J; THOMPSON RICHARD C; WILKIE STEPHEN C; STACK DOUGLAS R; SHI QING
    摘要:Compounds of formula (I), wherein W is a cyclic group of the type (2); (3); Y is represented by the formula (II); these compounds inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:WO-9966934-A1
    优先权日:1998-06-22
    标 题 :CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
    发明人:AUDIA JAMES E; DRESSMAN BRUCE A; SHI QING
    权利人:ELAN PHARM INC; LILLY CO ELI; AUDIA JAMES E; DRESSMAN BRUCE A; SHI QING
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:US-6774125-B2
    优先权日:1998-06-22
    标 题:Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:AUDIA JAMES E; THOMPSON RICHARD C; WILKIE STEPHEN C; BRITTON THOMAS C; PORTER WARREN J; HUFFMAN GEORGE W; LATIMER LEE H
    权利人:ELAN PHARM INC; LILLY CO ELI
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:US-6509331-B1
    优先权日:1998-06-22
    标题:Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:AUDIA JAMES E; THOMPSON RICHARD C; WILKIE STEPHEN C; BRITTON THOMAS C; PORTER WARREN J; HUFFMAN GEORGE W; LATIMER LEE H
    权利人:ELAN PHARM INC; LILLY CO ELI
    摘要:Disclosed are compounds which inhibit beta-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits beta-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:US-6906056-B2
    优先权日:1998-06-22
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:THOMPSON RICHARD C; WILKIE STEPHEN; STACK DOUGLAS R; VANMETER ELDON E; SHI QING; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; HENRY STEVEN S; MCDANIEL STACEY L; STUCKY RUSSELL D; PORTER WARREN J
    权利人:LILLY CO ELI
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.
    济宁心和化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.xinhechem.cn
    企业联系电话:15318402391👤
    📞济宁心和化工有限公司 ⚠️参考联系方式
    联系人:李丽
    电话:15318402391
    手机:15264160071
    传真:QQ: 1615850970
    邮箱:1615850970@qq.com
    通信地址: 济宁市任城区中德广场A座1305
    邮编: 250101
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:济宁市任城区中德广场A座1305
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Peter J Cragg, Et Al. Pillar[5]Arenes: Fascinating Cyclophanes With A Bright Future. Chem Soc Rev. 2012 Jan 21;41(2):597-607.

    合成参考文献


    摘要:Black, D. A.; Fagnou, K., Science of Synthesis, (2010) 45, 638.
    摘要:Kantchev, E. A. B.; Organ, M. G., Science of Synthesis, (2009) 48, 51.
    摘要:Mejuch, T.; Marek, I., Science of Synthesis: Cross Coupling and Heck-Type Reactions, (2012) 1, 773.
    摘要:Li, L.; Biscoe, M. R., Science of Synthesis: Cross Coupling and Heck-Type Reactions, (2012) 1, 813.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知